Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL

 

Conference Menu

Overview 
Pre-Conference Events
Register 
PDF Download
Conference-at-a Glance
Distinguished Faculty
Posters 
Hotel & Travel 
Sponsor / Exhibit
Press Pass 
Request Brochure 


 

Corporate Sponsors

Affymetrix

Almac Logo 2008

Covance

EMD Novagen

Ingenuity Systems Logo

msc

Nextbio Logo 2008

Next Gen Sciences

Proteome Sciences

Lead Sponsoring Publications

Bio-itworld

http://www.beyondgenome.com/sponsorlogos/Genetic_Engineering_News.jpg

http://chidb.com/logos/SCIENCE_AAAS.jpg
http://chidb.com/logos/thescienteist.jpg

Sponsoring Publications

Biophotonics

Cancer Biomarkers

Disease Markers

Current Drug Safety

Current Pharmacogenomics and Personalized Medicine

Current Proteomics

Proteome Sciences

Sponsoring Organization

biocenter 

Web Partners:

Bentham Science

Biolexis

PharmCast

SelectScience logo


Distinguished Faculty


 

  • Jonas S. Almeida, Ph.D., Abell-Hanger Distinguished Professor, Department of Bioinformatics and Computational Biology, The University of Texas, M.D. Anderson Cancer Center
  • Gil Alterovitz, Ph.D., Research Fellow, Children’s Hospital Informatics Program, Harvard/Massachusetts Institute of Technology, Division of Health Sciences and Technology; Research Affiliate, MIT Computer Science and Artificial Intelligence Laboratory
  • Adam Baker, Ph.D., Director, Diagnostic Product Development, Exiqon A/S
  • Sylvie Beaudenon, Ph.D., Senior Scientist, Asuragen, Inc.
  • Richard Beger. Ph.D., Branch Chief, Center for Metabolomics, Division of Systems Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration
  • Christoph Borchers, Ph.D., Associate Professor, Biochemistry & Microbiology, University of Victoria; Director, UVic–Genome BC Proteomics Centre
  • Laszlo G. Boros, M.D., Associate Professor of Pediatrics, University of California Los Angeles; Co-Director, Stable Isotope Research Laboratory, Harbor-UCLA Medical Center; Chief Scientific Advisor, SiDMAP, LLC
  • Alexander Buko, Ph.D., Director, Analytical Biochemistry and Proteomics, Biogen Idec
  • George A. Calin, M.D., Ph.D., Associate Professor, Experimental Therapeutics & Cancer Genetics, The University of Texas, M.D. Anderson Cancer Center
  • Mark R. Chance, Ph.D., Director, Case Center for Proteomics; Director, Center for Synchrotron Biosciences; Professor, Department of Physiology & Biophysics, Case Western Reserve University
  • Jake Chen, Ph.D., Assistant Professor, Informatics, Indiana University; Computer Science, Purdue University; Director, Indiana Center for Systems Biology and Personalized Medicine; Founder and Chief Executive Officer, MedeoLinx, LLC
  • Thomas P. Conrads, Ph.D., Associate Professor, Department of Pharmacology & Chemical Biology; Co-Director, Clinical Proteomics Facility, University of Pittsburgh Cancer Institute, Magee-Women’s Research Institute
  • A. Jamie Cuticchia, Ph.D., Director, Duke Bioinformatics, Duke Institute for Genome Sciences & Policy, Duke University Comprehensive Cancer Center
  • Viswanath Devanarayan, Ph.D., Director, Statistics, Biomarker Research, Abbott Laboratories
  • Bruno Domon, Ph.D., Group Leader, Institute of Molecular Systems Biology, Swiss Federal Institute of Technology, Zurich
  • Keith Elliston, Ph.D., President & Chief Executive Officer, Genstruct, Inc.
  • Mark T. Esser, Ph.D., Senior Research Fellow, Vaccines and Biologics Research, Merck Research Laboratories
  • Eric R. Fedyk, Ph.D., Head, Inflammation Biology & Immunotoxicology, Non-Clinical Development Sciences, Millennium Pharmaceuticals Inc.
  • Dean W. Felsher, M.D., Ph.D., Associate Professor, Division of Oncology, Stanford University
  • Felix Frueh, Ph.D., Vice President, Research & Development, Personalized Medicine,
    Medco Health Solutions, Inc.
  • Ying Ge, Ph.D., Director of Mass Spectrometry, Human Proteomics Program, School of Medicine and Public Health, University of Wisconsin-Madison
  • Mark Gerstein, Ph.D., Albert L. Williams Professor of Biomedical Informatics, Molecular Biophysics and Biochemistry, Computer Science, Yale University
  • Ira L. Goldknopf, Ph.D., Director, Proteomics, Power3 Medical Products, Inc.
  • Dave Goodlett, Ph.D., Professor, Medicinal Chemistry, University of Washington
  • G.A. Nagana Gowda, Ph.D., Research Scientist, Department of Chemistry, Purdue University
  • David F. Grant, Ph.D., Associate Professor of Toxicology; Co-Head, Mass Spectrometry Facility, Department of Pharmaceutical Sciences, University of Connecticut
  • Martin Grivorov, Ph.D., Head of Bioinformatics, Nestlé Research Center
  • Andrew Grupe, Ph.D., Senior Director, Pharmacogenomics; Director, CNS Research, Celera
  • Alberto Gutierrez, Ph.D., Deputy Director, New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration
  • Samir Hanash, Ph.D., Program Head, Molecular Diagnostics, Public Health Sciences, Fred Hutchinson Cancer Research Center
  • Joyce Hernandez, Ph.D., Manager, Global Data and Information Standards, Merck Research Labs
  • Joanna Hunter, Ph.D., Director, Protein Analysis, Caprion Proteomics
  • Saeed A. Jortani, Ph.D., Director, Toxicology, University of Louisville Hospital Laboratory; Associate Professor, Pathology and Laboratory Medicine, University of Louisville School of Medicine
  • Ananth Kadambi, Ph.D., Senior Scientist, Entelos, Inc.
  • Rima Kaddurah-Daouk, Ph.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center
  • Iya Khalil, Ph.D., Vice President and Co-Founder, Gene Network Sciences
  • Joshua LaBaer, M.D., Ph.D., Director, Institute of Proteomics, Harvard Medical School
  • Andrew N. Lane, Ph.D., J.G. Brown Chair of Structural Biology, Associate Director (NMR development) CREAM, J.G. Brown Cancer Center and Department of Chemistry, University of Louisville
  • Martin D. Leach, Ph.D., Executive Director, Basic Research & Biomarker IT, Merck & Co., Inc.
  • Jean Lee, Ph.D., Scientific Director, PKDM, Amgen Inc.
  • Michael N. Liebman, Ph.D., Senior Institute Fellow, Windber Research Institute; Managing Director, Strategic Medicine, Inc.
  • Johan Lindberg, Ph.D., Principal Scientist, Molecular Toxicology, Safety Assessment, AstraZeneca
  • James Lyons-Weiler, Ph.D., Director, Bioinformatics Analysis Core, Genomics and Proteomics Core Laboratories, Department of Biomedical Informatics, Department of Pathology, University of Pittsburgh Cancer Institute
  • Ruth E. March, Ph.D., Director, Personalized Healthcare Science and Technology;
    Lead, Personalized Healthcare Team, AstraZeneca
  • Stephen Naylor, Ph.D., Chief Executive Officer & Chairman, PPM, Inc.
  • Randall W. Nelson, Ph.D., Research Professor, Director of the Molecular Biosignatures Analysis Unit, The Biodesign Institute, Arizona State University
  • Alexey I. Nesvizhskii, Ph.D., Assistant Professor, Department of Pathology, University of Michigan Medical School
  • Christopher B. Newgard, Ph.D., Professor of Pharmacology and Cancer Biology, Professor of Internal Medicine, W. David and Sarah W. Stedman Distinguished Professor; Director, Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center
  • Thomas Papoian, Ph.D., D.A.B.T., Pharmacologist/Toxicologist, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research,U.S. Food and Drug Administration
  • Steven M. Patrie, Ph.D., Assistant Professor, Division of Translational Research, Department of Internal Medicine, University of Texas-Southwestern Medical Center
  • Shannon Payne, Ph.D., Senior Scientist, Epigenomics, Inc.
  • Istvan Pelczer, Ph.D., Lecturer, Senior NMR Spectroscopist, Department of Chemistry, Frick Lab, Princeton University
  • Emanuel F. Petricoin, Ph.D., Co-Director, Center for Applied Proteomics and Molecular Medicine, Professor of Life Sciences, George Mason University
  • Robert Plumb, Ph.D., Senior Applications Manager, Pharmaceutical Business Operations,
    Waters Corporation
  • Philip M. Pochon, Ph.D., Enterprise Information Architect, Covance, Inc.
  • Zhenhao Qi, Ph.D., Senior Principal Scientist, Translational Sciences, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Mitch Raponi, Ph.D., Principal Research Scientist, Biomarkers, Centocor Research & Development
  • Nandini Raghavan, Ph.D., Principal Biostatistician, Non-Clinical Biostatistics, Johnson & Johnson Pharmaceutical Research & Development
  • Prahlad T. Ram, Ph.D., Assistant Professor, Department of Systems Biology, The University of Texas, M.D. Anderson Cancer Center
  • Lisa Roberts Rapp, Ph.D., Research Cell/Molecular Biologist, GPRD, Advanced Technologies Gene Expression Analysis, Abbott Molecular, Inc.
  • Karin Rodland, Ph.D., Science Lead for NIH Programs, Pacific Northwest National Laboratory
  • Henry Rodriguez, Ph.D., M.B.A, Director, Clinical Proteomic Technologies for Cancer, Office of Technology and Industrial Relations, Office of the Director, National Cancer Institute
  • Jean-Charles Sanchez, Ph.D., Head, Biomedical Proteomics Group, Faculty of Medicine, Geneva University
  • Richard L. Seip, Ph.D., Senior Physiologist, Genomas, Inc.
  • Jan E. Schnitzer, M.D., Scientific Director, Professor of Cellular & Molecular Biology, Director of Vascular Biology & Angiogenesis Program, Sidney Kimmel Cancer Center
  • Kerstin Schmidt, M.D., Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins University School of Medicine
  • O. John Semmes, Ph.D., Anthem Professor for Cancer Research; Director, Center for Biomedical Proteomics, Eastern Virginia Medical School
  • Natalie J. Serkova, Ph.D., Associate Professor of Anesthesiology and Radiology; Director, Biomedical MRI/PET/CT Cancer Center Core, University of Colorado Health Sciences Center
  • Michael Shi, M.D., Ph.D., Director, Biomarker Project Leader, Exploratory Oncology Development, Novartis Pharmaceuticals Corp.
  • Vladimir Shulaev, Ph.D., Associate Professor, Virginia Polytechnic Institute & State University, Bioinformatics Institute
  • Ray Somorjai, Ph.D., Head, Biomedical Informatics, Institute for Biodiagnostics, National Research Council Canada
  • Sudhir Srivastava, Ph.D., Chief, Cancer Biomarkers Research Group, NIH National
    Cancer Institute
  • Judd Staples, Director, Translational Initiatives, Corporate and Venture Development, Institute for Genome Sciences & Policy, Duke University
  • Paul Tempst, Ph.D., Director, Protein Center, Member, Molecular Biology Program, Memorial Sloan-Kettering Cancer Center
  • Vladimir Tolstikov, Ph.D., Metabolomics Core Manager, The University of California Davis Genome Center
  • Zenta Tsuchihashi, Ph.D., Group Leader, Oncology Clinical Biomarker, Discovery Medicine and Clinical Pharmacology, Bristol-Myers Squibb Co.
  • Vishal S. Vaidya, Ph.D., Instructor in Medicine, Brigham & Women’s Hospital, Harvard Medical School
  • Jennifer Van Eyk, Ph.D., Director, The Hopkins NHLBI Proteomics Center; Director, Bayview Proteomics Group; Professor of Medicine, Division of Cardiology, Biological Chemistry and Biomedical Engineering, Johns Hopkins University
  • Scott A. Waldman, M.D., Ph.D., Chair, Department of Pharmacology and Experimental Therapeutics; Director, Gastrointestinal Malignancies Program, Kimmel Cancer Center, Thomas Jefferson University
  • William Wikoff, Ph.D., Research Associate, Center for Mass Spectrometry, Scripps Research Institute
  • David Wishart, Ph.D., Professor, Departments of Computing Science and Biological Sciences, University of Alberta
  • Taufika Islam Williams, Ph.D., Research Assistant Professor, W.M. Keck FT-ICR Mass Spectrometry Laboratory, Department of Chemistry, North Carolina State University
  • Xiang Zhang, Ph.D., Associate Professor, Analytical Chemistry, University of Louisville



Top Searches
By Series:
By Region:

Japan-Flag  Korea-Flag  China-Simplified-Flag  China-Traditional-Flag 

Conference
& Course Catalog

CHI Catalog 

Short Course DVDs